Digital Respiratory Healthcare – available now!

The latest ERS Monograph on Digital Respiratory Healthcare has now been published. Guiding the reader through the potential benefits and pitfalls of technology-based initiatives. this Monograph breaks the discussion down into three areas: technological opportunities and regulatory challenges; social benefits, challenges and implications; and exemplars of digital healthcare. Each chapter reviews contemporary literature and considers how a digital respiratory future can provide optimal care. The result is an authoritative, balanced guide to developing digital respiratory health. 

Access the Monograph online | Order your print copy

The ERS Monograph podcast: listen to the newest episodes

The ERS Monograph podcast provides a fascinating overview of the latest instalments in our book series. Each episode looks at a different Monograph, with interviews featuring Guest Editors and leaders in the field. On the ERS Respiratory Channel, you'll find podcast episodes on rare diseases of the respiratory system, inequalities in respiratory health, lung diseases and cancer, and much more. Visit the ERS Respiratory Channel to listen to the podcasts and access the Monograph at books.ersjournals.com 

Breathe: Multidisciplinary management of respiratory disease

The latest issue of Breathe examines multidisciplinary management of respiratory disease, with articles looking at holistic management of patients with progressive pulmonary fibrosis and the multidisciplinary teams involved in TB prevention and care. The journal club discusses recent trials of add-on therapy for pulmonary fibrosis.

Read the introductory editorial from the Breathe Chief Editor | Browse the table of contents

European Lung Foundation – Breathe Clean Air patient conference

Held on 7 December, this European Lung Foundation (ELF) patient conference will see patients and healthcare professionals discuss the effects of air pollution and climate change on lung conditions. The conference will include a collection of patient stories on the effects of indoor and outdoor pollution. Patients will give their advice on mitigation and healthcare professionals will provide an update on new research and advice. The even will highlight the importance of patient voices in advocating for better policies.

Register now | Order your print copy of Inequalities in Respiratory Health

Adult Cystic Fibrosis Conference

On 1–2 December, the European Respiratory Society (ERS) and the European Cystic Fibrosis Society (ECFS), will hold the Adult Cystic Fibrosis Conference. Chaired by Francesco Blasi and Eva Polverino, this conference will provide an overview of the diagnosis, treatment and continuous management of cystic fibrosis (CF), including transitioning from paediatric to adult CF care. Delegates will have the chance to participate in interactive sessions, and submit cases and abstracts for presentation and discussion. Register for #ACFMilan2023

Special offer – €10 off print copies of Bronchiectasis for a limited time to mark #ACFMilan 2023

Weaning from mechanical ventilation: lessons learned from WEAN SAFE

WEAN SAFE is a European Respiratory Society (ERS) co-funded clinical research collaboration of 50 countries and 500 intensive care units from around the globe. Its aim is to investigate the epidemiology, practice and outcome of weaning from mechanical ventilation. On 5 December, ERS will hold a webinar that will discuss the findings and implications of the first WEAN SAFE results. With Giacomo Bellani, Margaret Herridge and John Laffey amongst the speakers, this webinar will prove valuable to pulmonologists, nurses and clinical scientists alike.

Register now | Order your print copy of the ERS Practical Handbook of Invasive Mechanical Ventilation

Multidisciplinary management of pulmonary fibrosis

On 29 November, the European Respiratory Society (ERS) will hold a webinar on "Multidisciplinary management of pulmonary fibrosis: focus on patient centeredness". Aimed at pulmonologists, clinicians, patients and interstitial lung disease (ILD) specialists, the webinar will consider the following topics: beyond pharmacological treatment in pulmonary fibrosis; ventilatory support in ILD; and nonpharmacological treatments and health literacy. 

Register now | Order your print copy of Pulmonary Manifestations of Systemic Diseases

ERJ pick of the week

Impaired fibroblast growth factor (FGF)10 signalling is an integral part of the pathological mechanism that leads to development of cigarette smoke-induced emphysema and pulmonary hypertension (PH). Restoration of FGF10 signalling reverses established cigarette smoke- and elastase-induced emphysema and PH in mice.

Read the article in full | Browse the current issue of the ERJ

Coming soon in the ERS Monograph series

Look out for the following titles, coming soon in the ERS Monograph book series: Digital Respiratory Healthcare (pre-order before 27 November and receive a €10 discount), COPD in the 21st Century, Transition of Care in Respiratory Medicine and COVID-19: An Update. Visit ersbookshop.com to browse all the titles in the ERS Monograph collection.

A new dawn in the fight against TB: UNITE4TB starts phase 2 clinical trials

On 8 November 2023, leading tuberculosis (TB) drug developer, UNITE4TB, of which the European Respiratory Society (ERS) is a consortium member, announced the start of its phase 2B/C clinical trial programme, with the first participant enrolled at its trial site in Cappe Town, South Africa. These trials are a major milestone for the TB community.

Find out more | Order your print copy of The Challenge of Tuberculosis in the 21st Century 

Support Tobacco 21 this Lung Cancer Awareness Month

The European Respiratory Society (ERS) supports the Tobacco 21 campaign, urging policy makers to take positive action against the uptake of smoking, by raising the tobacco age-of-sale to 21. As countries move towards ending the use of tobacco products, ERS urges its members to support and promote the adoption of Tobacco 21 policies.

Find out more about Tobacco 21 | Order your print copy of the Monograph on Supporting Tobacco Cessation

Digital Respiratory Healthcare – pre-order your print copy

The forthcoming ERS Monograph on Digital Respiratory Healthcare is now available to pre-order. An authoritative, up-to-date and balanced guide to the developing digital respiratory health field, this Monograph deftly guides the reader through the potential benefits and pitfalls of such change. 

Pre-order your print copy before 27 November and receive a €10 discount 

The importance of getting the dose right in anti-TB treatment

On 23 November, ERS will host a panel discussion on "The importance of getting the dose right in anti-tuberculosis treatment". Chaired by Professor Christoph Lange and Professor Raquel Duarte, this webinar will discuss: the main pharmacodinetic processes; site-of-disease pharmacodkinetics in pulmoanry TB; combination treatment and drug–drug interactions; and the use of mathematical models.

Register now | Order your print copy of the The Challenge of Tuberculosis in the 21st Century

Access the latest ERJ Open Research articles

ERJ Open Research is ERS's fully open access research journal. Amongst the latest articles in the journal, you'll find research letters on compartment-specific protein interactions in beryllium lung disease and patient and physician perspectives on biological treatment in severe asthma; and an original research article association of weather conditions with variability in physical activity in COPD. The issue also includes Review articles on pulmonary hypertension associated with diazoxide, and on the influence of ethnicity on adherence to nonsurgical interventions for COPD. Visit openres.ersjournals.com to browse all of the latest articles in full.

European Respiratory Review: pick of the week

Individuals with preserved ratio impaired spirometry (PRISm) have a significantly increased risk of all-cause, cardiovascular and respiratory-related mortality compared with those with normal spirometry. These findings highlight the importance of recognising PRISm in clinical settings.

Read the pick of the week | Submit your manuscript to the European Respiratory Review

Clean air in Europe: no delay, no exemptions, no more pollution

As the EU Environment Council prepares to adopt its position on the revision of the EU Ambient Air Quality Directive, the European Respiratory Society (ERS) and the European Lung Foundation (ELF) have issued a new position statement urging EU environment ministers to prioritise health, follow the science on health effects of air pollution, and fully align new EU air quality standards with the World Health Organization 2021 Air Quality Guidelines.

Read the statement | Order your print copy of Inequalities in Respiratory Health

Non-CF bronchiectasis in children: improving patient care

On 20 November, ERS will host a panel discussion on "Non-CF bronchiectasis in children: improving patient care". Chaired by Dr Carolina Arez Constant and Dr Ahmad Kantar, this webinar will discuss: the patient perspective of living with bronchiectasis; undiagnosed bronchiectasis in children; and outgrowing paediatric care in bronchiectasis.

Register now | Order your print copy of the ERS Monograph on Bronchiectasis

Corrected Impact Factor released for ERJ

The 2022 Journal Impact Factor of the European Respiratory Journal (ERJ) has been corrected to 24.9 by Clarivate, which now places the ERJ as the second highest impact journal in the Respiratory Systems category.

Access the full range of ERS Publications | Submit to the ERJ

Digital Respiratory Healthcare – pre-order your print copy

The forthcoming ERS Monograph on Digital Respiratory Healthcare is now available to pre-order. An authoritative, up-to-date and balanced guide to the developing digital respiratory health field, this Monograph deftly guides the reader through the potential benefits and pitfalls of such change. 

Pre-order your print copy before 27 November and receive a €10 discount 

ERJ Editors' choice

The Chief Editors of the European Respiratory Journal (ERJ) have selected their highlights from the October issue. Their selection includes original articles on: theratyping cystic fibrosis patients, the association of eicosanoids and eicosanoid-related metabolites with pulmonary hypertension, and the prevalence, risk factors and outcomes of cardiac disease. The issue also features European Respiratory Society (ERS) short guidelines for the use of as-needed ICS/formoterol in mild asthma, as we all as the ERS/American Thoracic Society technical statement on standardisations of the measurement of lung volumes.

Access the Chief Editors' full list | Visit erj.ersjournals.com to browse the the most highly regarded respiratory journal in Europe

Using human induced pluripotent stem cells for lung research

Session three of the webinar series "How to? Technologies used on clinical samples" takes place on 15 November and is entitled "Using human induced pluripotent stem cells for lung research". Chaired by Dr Ruth Olmer, the webinar will discuss; differentiation of lung tissue-relevant cell types from hiPSC; CRISPR/Cas9 gene editing of hiPSC; and patient-specific and disease modelling. 

Register now | Order your print copy of Lung Stem Cells in Development, Health and Disease

ERJ: pick of the week

People living with cystic fibrosis may be at increased risk of cardiac disease as they grow older. Further work is needed to better understand risk factors and risk profiles in more detail.

Read the article in full | Browse the current issue of the ERJ

ERS short guidelines for the use of as-needed ICS/formoterol in mild asthma

As part of the October issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin and Professor Alberto Papi discuss the new ERS short guidelines for the use of as-needed ICS/formoterol in mild asthma.

Listen to the episode | Access the October issue of the ERJ

Novel advances in the diagnosis of ILDs

In a recent joint webinar, ERS and ALAT looked at novel advances in the diagnosis of interstitial lung diseases (ILDs). The webinar covers the importance of the usual interstitial pneumonia (UIP) pattern, the role of cryobiopsy in the diagnosis of fibrotic ILD, and genomic classifiers as a diagnostic tool to identify the UIP pattern in clinical practice. 

Register now | Order your copy of the ERS Monograph on Pulmonary Manifestations of Systemic Diseases

Digital Respiratory Healthcare – pre-order your print copy

The forthcoming ERS Monograph on Digital Respiratory Healthcare is now available to pre-order. An authoritative, up-to-date and balanced guide to the developing digital respiratory health field, this Monograph deftly guides the reader through the potential benefits and pitfalls of such change. 

Pre-order your print copy before 27 November and receive a €10 discount 

European Respiratory Review: pick of the week

While blood eosinophil count is the biomarker used in clinical practice to enable selective use of inhaled corticosteroids (ICS) in COPD, there is a complex interacting network involving the microbiome, airway inflammation and ICS that decides the clinical outcome in individuals.

Read the pick of the week | Submit your manuscript to the European Respiratory Review

Curbside Consult: sleep disordered breathing

In the latest episode of Curbside Consult, Professor Sean Gaine and Dr Emer Kelly get an update from the field of sleep disordered breathing, including the latest on treatment, from Dr Esther Schwarz.

Watch now | Order your print copy of the ERS Handbook of Respiratory Sleep Medicine

Breathe: Multidisciplinary management of respiratory disease

The latest issue of Breathe examines multidisciplinary management of respiratory disease, with articles looking at holistic management of patients with progressive pulmonary fibrosis and the multidisciplinary teams involved in TB prevention and care. The journal club discusses recent trials of add-on therapy for pulmonary fibrosis.

Read the introductory editorial from the Breathe Chief Editor | Browse the table of contents